India Globalization Capital, Inc. Stock Nyse
Equities
US45408X3089
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 1.24M | Sales 2025 * | 1.4M | Capitalization | 28.41M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -10M | EV / Sales 2024 * | 22.9 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 20.3 x |
P/E ratio 2024 * |
-1.95
x | P/E ratio 2025 * |
-2.69
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.56% |
Managers | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 05-04-28 |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 18-05-08 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 05-04-28 |
Richard Prins
CHM | Chairman | 67 | 07-04-30 |
Director/Board Member | 78 | 22-01-17 |
1st Jan change | Capi. | |
---|---|---|
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |